Get the Stockscreener App
3.35
0.30%
-0.010
After Hours:
3.41
0.06
+1.79%
Oncology Institute Inc stock is traded at $3.35, with a volume of 1.54M.
It is down -0.30% in the last 24 hours and down -12.76% over the past month.
The Oncology Institute Inc offers oncology services committed to improving cancer prevention, diagnosis, treatment, research, and education. The company provides services including infusion centres. In-house dispensary, Outpatient blood transfusion, Outpatient stem cell transplant, financial counseling, clinical trials, comprehensive lab testing, and end-of-life counseling. The business operates in three operating segments dispensary, patients services and clinical trials and others. Key revenue is earned from providing patient services. Majority of revenue is from patients services.
See More
Previous Close:
$3.36
Open:
$3.35
24h Volume:
1.54M
Relative Volume:
0.67
Market Cap:
$329.58M
Revenue:
$361.07M
Net Income/Loss:
$-71.54M
P/E Ratio:
-4.2405
EPS:
-0.79
Net Cash Flow:
$-47.97M
1W Performance:
-19.86%
1M Performance:
-12.76%
6M Performance:
+3.72%
1Y Performance:
+590.72%
1-Day Range:
$3.335
$3.50
1-Week Range:
$3.21
$4.25
52-Week Range:
$0.44
$4.88
Oncology Institute Inc Stock (TOI) Company Profile
Name
Oncology Institute Inc
Sector
Industry
Phone
562-735-3226
Address
18000 STUDEBAKER RD, CERRITOS
Compare TOI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TOI
Oncology Institute Inc
|
3.35 | 330.56M | 361.07M | -71.54M | -47.97M | -0.79 |
|
HCA
Hca Healthcare Inc
|
469.29 | 110.40B | 74.37B | 7.31B | 8.10B | 25.88 |
|
THC
Tenet Healthcare Corp
|
196.74 | 17.69B | 20.69B | 2.40B | 1.55B | 15.62 |
|
FMS
Fresenius Medical Care Ag Adr
|
21.95 | 12.54B | 21.23B | 924.30M | 2.22B | 1.2272 |
|
UHS
Universal Health Services Inc
|
199.88 | 12.76B | 16.08B | 1.20B | 1.06B | 17.82 |
|
ENSG
Ensign Group Inc
|
180.57 | 10.63B | 4.11B | 239.98M | 193.10M | 4.12 |
Oncology Institute Inc Stock (TOI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-25-25 | Initiated | Needham | Buy |
| Jul-23-25 | Initiated | Noble Capital Markets | Outperform |
| Jul-16-25 | Initiated | B. Riley Securities | Buy |
| May-15-25 | Initiated | BTIG Research | Buy |
| Feb-26-24 | Resumed | Jefferies | Buy |
| Sep-14-22 | Initiated | Guggenheim | Buy |
| Aug-15-22 | Initiated | Jefferies | Buy |
View All
Oncology Institute Inc Stock (TOI) Latest News
Downgrade Watch: What is the implied volatility of The Oncology Institute IncJuly 2025 Opening Moves & Verified Swing Trading Watchlists - baoquankhu1.vn
ETF Watch: Is The Oncology Institute Inc Equity Warrant a potential multi baggerJuly 2025 Trade Ideas & Risk Controlled Swing Alerts - baoquankhu1.vn
Dividend Watch: Is The Oncology Institute Inc Equity Warrants ROE strong enoughWeekly Earnings Recap & Weekly Momentum Picks - baoquankhu1.vn
The Oncology Institute Announces Leadership Promotions - 富途牛牛
Market Recap: Will The Oncology Institute Inc stock maintain momentum in 2025 - Bộ Nội Vụ
The Oncology Institute reaffirms 2025 guidance, projects 2026 revenue - MSN
The Oncology Institute Reaffirms 2025 Guidance And Provides Preliminary 2026 Outlook - TradingView — Track All Markets
The Oncology Institute Reaffirms 2025 Guidance and Provides Preliminary 2026 Outlook - The Manila Times
Cancer care group projects growth and first full year of adjusted profit - Stock Titan
Is Oncology Institute’s (TOI) New Tech‑Heavy Leadership Team Quietly Reframing Its Value‑Based Care Ambitions? - simplywall.st
U.S. Neurology Associates Partners with M33 Growth to Transform Neurological Care - GlobeNewswire Inc.
Is Oncology Institute (TOI) Quietly Rewiring Its Edge Around AI Talent And Boardroom Financial Discipline? - Yahoo Finance
The Oncology Institute Announces Promotions of Rakesh Panda to Chief Information Officer and Nolan Mariano to Chief People Officer - Quiver Quantitative
Is The Oncology Institute Inc. stock a buy before product launchesMarket Performance Report & Risk Controlled Swing Trade Alerts - Улправда
Will The Oncology Institute Inc. stock attract more institutional investorsJuly 2025 Update & Daily Chart Pattern Signal Reports - Улправда
Will The Oncology Institute Inc. stock gain from strong economyMarket Activity Summary & High Conviction Buy Zone Picks - Улправда
Can The Oncology Institute Inc. stock deliver surprise earnings beatMarket Performance Summary & Expert Verified Stock Movement Alerts - Улправда
Will The Oncology Institute Inc. Equity Warrant stock deliver consistent dividendsEarnings Performance Report & Weekly Top Gainers Trade List - Улправда
Can The Oncology Institute Inc. Equity Warrant stock rebound after recent weakness2025 Fundamental Recap & Target Return Focused Picks - Улправда
How The Oncology Institute Inc. Equity Warrant stock trades during market volatilityIndex Update & Weekly Setup with ROI Potential - Улправда
Why The Oncology Institute Inc. Equity Warrant stock could see breakout soonWeekly Market Report & Low Drawdown Investment Ideas - Улправда
The $537B Precision Pivot: Why Molecular Monitoring is the New Oncology Standard - The Globe and Mail
Oncology Institute Adds Independent Director and Audit Chair - TipRanks
For Oncology Institute Insiders, Selling US$644k Of Shares Was A Smart Move - simplywall.st
The Oncology Institute Announces Addition of Board Member Mark Stolper - marketscreener.com
Cancer care group adds veteran CFO to its board of directors - Stock Titan
Can The Oncology Institute Inc. Equity Warrant stock sustain free cash flow growth2025 Dividend Review & Technical Entry and Exit Tips - Улправда
Will The Oncology Institute Inc. Equity Warrant stock reach Wall Street targetsJuly 2025 Recap & Expert Approved Trade Ideas - Улправда
Will The Oncology Institute Inc. stock gain from government policiesMarket Growth Report & Momentum Based Trading Signals - Улправда
Is The Oncology Institute Inc. Equity Warrant stock a top pick in earnings seasonJuly 2025 Action & Low Risk Profit Maximizing Plans - Улправда
How institutional buying supports The Oncology Institute Inc. stockEarnings Trend Report & Weekly Momentum Stock Picks - Bölüm Sonu Canavarı
How The Oncology Institute Inc. Equity Warrant stock reacts to oil pricesPortfolio Growth Summary & Weekly Market Pulse Updates - Улправда
Take Profit: Will The Oncology Institute Inc. Equity Warrant stock benefit from infrastructure spending2025 Price Action Summary & Technical Pattern Alert System - ulpravda.ru
The Caris Precision Oncology Alliance Welcomes Providence Swedish Cancer Institute - Sahm
How The Oncology Institute Inc. Equity Warrant stock performs in stagflationShare Buyback & Fast Gain Swing Trade Alerts - DonanımHaber
Update Recap: How The Oncology Institute Inc. Equity Warrant stock reacts to oil pricesJuly 2025 Intraday Action & Consistent Profit Focused Trading Strategies - Улправда
Will The Oncology Institute Inc. Equity Warrant stock keep outperforming rivalsMarket Performance Report & Daily Technical Forecast Reports - DonanımHaber
The Oncology Institute: Making Progress (NASDAQ:TOI) - Seeking Alpha
Is The Oncology Institute Inc. stock supported by strong fundamentals2025 Pullback Review & Community Consensus Trade Signals - Улправда
Brad Hively Sells 13,333 Shares of Oncology Institute (NASDAQ:TOI) Stock - MarketBeat
Oncology Institute Director Sells Shares to Cover Tax Liabilities - TradingView — Track All Markets
Officer/Dir Hively Surrenders 13,333 Of Oncology Institute Inc [TOI] - TradingView — Track All Markets
TOI (NASDAQ: TOI) notice covers planned Rule 144 sale of 13,333 shares - Stock Titan
MSN Money - MSN
Wall Street analysts’ outlook for Oncology Institute Inc (TOI) - setenews.com
Can The Oncology Institute Inc. Equity Warrant stock deliver strong Q4 earnings2025 Short Interest & Growth Focused Entry Point Reports - Newser
How The Oncology Institute Inc. Equity Warrant stock compares to market leadersMarket Sentiment Report & Weekly Sector Rotation Insights - Newser
TOIIW SEC FilingsThe Oncology Institute Inc 10-K, 10-Q, 8-K Forms - Stock Titan
This trade activity should not be overlooked: Oncology Institute Inc (TOI) - setenews.com
The Caris Precision Oncology Alliance Welcomes UAMS Winthrop P. Rockefeller Cancer Institute - Yahoo Finance
Why The Oncology Institute Inc. Equity Warrant stock could benefit from AI revolutionPortfolio Profit Report & AI Based Buy/Sell Signal Reports - Newser
Oncology Institute Inc Stock (TOI) Financials Data
Revenue
Net Income
Cash Flow
EPS
Oncology Institute Inc Stock (TOI) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Hively Brad | Director |
Dec 15 '25 |
Sale |
3.77 |
13,333 |
50,291 |
683,721 |
0.22%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):